Future of drugs-Diabetes_Ranirestat

Drug Name	Ranirestat
Structure
Drug Code	AS-3201
Synonym	(3R)-2'-(4-bromo-2-fluorobenzyl)-1'H,2H,5H-spiro[pyrrolidine-3,4'-pyrrolo[1,2-a]pyrazine]-1',2,3',5(2'H)-tetrone
Molecular Formula	C17H11BrFN3O4
Innovator	Dainippon Sumitomo Pharma PharmaKyorin
Condition	Diabetic nephropathy (Orphan drug status)
Mechanism of Action	Aldose reductase inhibitor
Clinical Phase	III in USA